Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Voyager Therapeutics

Request full access

Gene therapies for neurological diseases crossing blood-brain barrier.

Cambridge, United StatesFounded 2014Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2015

Voyager Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Voyager Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later10 investors entered at this stage

Employees mapped 161 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$42M

80 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Voyager Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.